A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of AIR645 in Healthy Subjects and Subjects With Controlled Asthma.

Trial Profile

A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of AIR645 in Healthy Subjects and Subjects With Controlled Asthma.

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Sep 2009

At a glance

  • Drugs AIR 645 (Primary)
  • Indications Asthma
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Sep 2009 Results were presented at the European Respiratory Society Annual Congress in Vienna, according to a Altair Therapeutics media release.
    • 26 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 19 May 2009 Results have been presented at the 2009 International Conference of the American Thoracic Society within a Mini-Symposium according to an Altair Therapeutics media release. Results were also reported in the media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top